Loading company…
Paris-based Pixium Vision develops vision restoration technology, including the PRIMA retinal implant, for advanced macular degeneration.
Founded in 2011 in Paris, France, Pixium Vision SA designs vision restoration technologies. Its PRIMA System pairs a retinal implant with camera-equipped glasses for patients with advanced macular degeneration, and it targets hospitals and ophthalmology clinics in France, Germany and Italy. The company raised EUR 34.50 mn in its IPO, which is its total funding, and Kreos Capital recently invested. Its 2022 revenue was EUR 0, with EBITDA of EUR -14,788,349.80.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in